Eastern Mediterranean Countries Deserve Better Health: Will the New WHO Regional Director Deliver That? 24/08/2023 Mukesh Kapila For most people, electing the regional director – or chief health officer – for the Eastern Mediterranean Region (EMRO) of the World Health Organization (WHO) will not set the pulse racing. Is this just another shuffling of chairs around the world’s bureaucratic table? Even among global health nerds, it will trigger just a faint tremor. […] Continue reading -> World Needs to Dramatically Scale Up Hepatitis Testing and Treatment 28/07/2023 Mandi Smallhorne Viral hepatitis could become a more lethal killer than malaria, tuberculosis and HIV combined by 2040, if current trends in undetected infection and treatment continue, warned the World Health Organisation (WHO) on Friday, World Hepatitis Day. In observance of the day, WHO launched a call, under the title “One life, one liver”, to scale up […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
World Needs to Dramatically Scale Up Hepatitis Testing and Treatment 28/07/2023 Mandi Smallhorne Viral hepatitis could become a more lethal killer than malaria, tuberculosis and HIV combined by 2040, if current trends in undetected infection and treatment continue, warned the World Health Organisation (WHO) on Friday, World Hepatitis Day. In observance of the day, WHO launched a call, under the title “One life, one liver”, to scale up […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts
Lives Are At Risk as Anti-Abortion Groups Attack HIV Programme PEPFAR 20/06/2023 Kerry Cullinan One of the most successful US aid programmes, the US President’s Emergency Plan for AIDS Relief (PEPFAR) – which has saved 25 million lives in its 20 years of existence – is facing a right-wing backlash based on misinformation. PEPFAR’s five-year budget is due for re-funding by the US Senate and Congress by 30 September, […] Continue reading -> Posts navigation Older postsNewer posts